Who Supplies Lenalidomide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Lenalidomide exports, with 237+ registered manufacturers shipping to buyers across 122+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 53.8% (export value: $475.2M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (19.4%, $171.3M). DR REDDYS LABORATORIES LIMITED (14.8%, $130.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Lenalidomide? Top Manufacturers & Their Buyers
Flow of Lenalidomide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Lenalidomide Supplier Network — Key Market Intelligence
The Lenalidomide export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 53.8% share, shipping $475.2M worth of product across 144 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $171.3M (19.4%) to the overall market. Combined, the top two suppliers alone account for 73.2% of all Lenalidomide exports, indicating a relatively concentrated supply base.
Across all 237 tracked manufacturers, the total Lenalidomide export value stands at $883.1M from 2.7K shipments. The market average shipment value is $324.2K. The single largest buyer relationship in terms of trade value is SUN PHARMACEUTICAL INDUSTRIES,INC.., receiving $190.9M worth of product.
The combined buyer network spans 21 named purchasing companies, including SUN PHARMACEUTICAL INDUSTRIES,INC.., 2 INDEPENDENCE WAY P, AUROBINDO PHARMA USA INC, INTER PHARMA S.A.L,,, EUGIA PHARMA MALTA L and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Lenalidomide exporter from India, with a market share of 53.8% and a total export value of $475.2M across 144 shipments. Their average shipment value of $3.3M is above the market average of $324.2K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $190.9M across 58 shipments (40.2% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $126.6M across 38 shipments (26.6% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $100.8M across 31 shipments (21.2% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $49.4M across 15 shipments (10.4% of this supplier's total exports)
• 2 INDEPENDENCE WAY P — $7.4M across 2 shipments (1.6% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $3.3M is 918% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Lenalidomide exporter from India, with a market share of 19.4% and a total export value of $171.3M across 189 shipments. Their average shipment value of $906.2K is above the market average of $324.2K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. AUROBINDO PHARMA USA INC is the dominant customer, accounting for 67.0% of this supplier's tracked business. Top customers include:
• AUROBINDO PHARMA USA INC — $114.8M across 127 shipments (67.0% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $52.2M across 58 shipments (30.5% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $3.6M across 4 shipments (2.1% of this supplier's total exports)
• INTER PHARMA S.A.L,, — $371.4K across 0 shipments (0.2% of this supplier's total exports)
• EUGIA PHARMA MALTA L — $331.2K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $906.2K is 180% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.
3DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the third-largest Lenalidomide exporter from India, with a market share of 14.8% and a total export value of $130.7M across 4 shipments. Their average shipment value of $32.7M is above the market average of $324.2K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 4 named buyers in our database. DR REDDYS LABORATORI is the dominant customer, accounting for 99.8% of this supplier's tracked business. Top customers include:
• DR REDDYS LABORATORI — $130.5M across 4 shipments (99.8% of this supplier's total exports)
• Dr Reddy s Laborator — $109.6K across 0 shipments (0.1% of this supplier's total exports)
• PHARMACIE CENTRALE D — $54.2K across 0 shipments (0.0% of this supplier's total exports)
• DR REDDYS LABORATORI — $45.4K across 0 shipments (0.0% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $32.7M is 9980% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.
4CIPLA LIMITED
CIPLA LIMITED is the fourth-largest Lenalidomide exporter from India, with a market share of 9.0% and a total export value of $79.8M across 42 shipments. Their average shipment value of $1.9M is above the market average of $324.2K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 96.5% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $77.0M across 41 shipments (96.5% of this supplier's total exports)
• CIPLA COLOMBIA SAS Y O DEPOSITO UPS — $1.3M across 1 shipments (1.6% of this supplier's total exports)
• CIPLA COLOMBIA SAS — $929.7K across 0 shipments (1.2% of this supplier's total exports)
• MEDPRO PHARMACEUTICA — $361.8K across 0 shipments (0.5% of this supplier's total exports)
• MEDPRO PHARMACEUTICA — $238.0K across 0 shipments (0.3% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $1.9M is 486% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.
5HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Lenalidomide exporter from India, with a market share of 0.6% and a total export value of $5.6M across 23 shipments. Their average shipment value of $241.9K is below the market average of $324.2K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. XXC (XXNG XXNG)XXO XXD is the dominant customer, accounting for 99.4% of this supplier's tracked business. Top customers include:
• XXC (XXNG XXNG)XXO XXD — $5.5M across 23 shipments (99.4% of this supplier's total exports)
• XXVENXXHARXX DRXXRL — $15.0K across 0 shipments (0.3% of this supplier's total exports)
• XXVENXXHARXX HOXXURA — $9.5K across 0 shipments (0.2% of this supplier's total exports)
• XXVENXXHARXX ELXXALV — $5.3K across 0 shipments (0.1% of this supplier's total exports)
• XXAROXXPHAXXA BXX — $5.1K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $241.9K, indicating a broad distribution network with many smaller, regular orders.
6RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Lenalidomide exporter from India, with a market share of 0.4% and a total export value of $3.7M across 281 shipments. Their average shipment value of $13.1K is below the market average of $324.2K, reflecting a high-volume, competitive pricing strategy.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PHARMIS SARL — $1.1M across 83 shipments (29.7% of this supplier's total exports)
• BROCACEF HEALTHCARE LOGISTICS BV — $1.1M across 81 shipments (28.9% of this supplier's total exports)
• BROCACEF HEALTHCARE LOGISTICS BV — $701.9K across 53 shipments (19.0% of this supplier's total exports)
• TURGUT ILACLARI A S — $422.6K across 32 shipments (11.4% of this supplier's total exports)
• DHL DIDCOT — $404.8K across 31 shipments (11.0% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (281 shipments) at a per-shipment value of $13.1K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Lenalidomide Flows
Once Lenalidomide leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $883.1M. United States absorbs the largest share at 96.7% ($853.7M), followed by Japan (0.6%) and Netherlands (0.4%).
In United States — the top destination — named importers include SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIESINC., AUROBINDO PHARMA USA., INC,. In Japan, key buyers are XXC (XXNG XXNG)XXO XXD.
This geographic spread reflects Lenalidomide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Lenalidomide Go? Top Importing Countries & Their Buyers
Trade flow of Lenalidomide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Lenalidomide imports from India, with a total trade value of $853.7M across 79 shipments — representing a 96.7% share of all Lenalidomide exports. The average shipment value of $10.8M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Lenalidomide importers in United States: SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest buyer, accounting for 22.4% ($190.9M) of this market's total imports.
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $190.9M (22.4% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIESINC. — $126.6M (14.8% of United States's total)
• AUROBINDO PHARMA USA., INC, — $114.8M (13.4% of United States's total)
Key Insight: United States's per-shipment average of $10.8M (3233% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Lenalidomide imports from India.
2Japan
Japan ranks as the second-largest destination for Lenalidomide imports from India, with a total trade value of $5.5M across 2 shipments — representing a 0.6% share of all Lenalidomide exports. The average shipment value of $2.8M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lenalidomide importers in Japan: XXC (XXNG XXNG)XXO XXD is the largest buyer, accounting for 100.0% ($5.5M) of this market's total imports.
• XXC (XXNG XXNG)XXO XXD — $5.5M (100.0% of Japan's total)
Key Insight: Japan's per-shipment average of $2.8M (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Japan is a key market for Lenalidomide imports from India.
3Netherlands
Netherlands ranks as the third-largest destination for Lenalidomide imports from India, with a total trade value of $3.8M across 85 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $45.3K is below the global average of $324.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Lenalidomide importers in Netherlands: BROCACEF NL HUB is the largest buyer, accounting for 50.9% ($2.0M) of this market's total imports.
• BROCACEF NL HUB — $2.0M (50.9% of Netherlands's total)
• BROCACEF HEALTHCARE LOGISTICS BV — $1.1M (27.8% of Netherlands's total)
Key Insight: Netherlands receives frequent, smaller shipments of Lenalidomide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Netherlands is a key market for Lenalidomide imports from India.
4Canada
Canada ranks as the fourth-largest destination for Lenalidomide imports from India, with a total trade value of $3.8M across 8 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $471.8K is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Lenalidomide importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 25.6% ($966.5K) of this market's total imports.
• TARO PHARMACEUTICALS INC., — $966.5K (25.6% of Canada's total)
• TARO PHARMACEUTICALS INC — $966.0K (25.6% of Canada's total)
• TARO PHARMACEUTICALS INC. — $949.1K (25.1% of Canada's total)
Key Insight: Canada's per-shipment average of $471.8K (46% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Lenalidomide imports from India.
5Colombia
Colombia ranks as the fifth-largest destination for Lenalidomide imports from India, with a total trade value of $3.1M across 3 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $1.0M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lenalidomide importers in Colombia: CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the largest buyer, accounting for 39.9% ($1.3M) of this market's total imports.
• CIPLA COLOMBIA SAS Y O DEPOSITO UPS — $1.3M (39.9% of Colombia's total)
Key Insight: Colombia's per-shipment average of $1.0M (223% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Lenalidomide imports from India.
People Also Ask — Lenalidomide Supplier & Trade Network
Who are the top suppliers of Lenalidomide from India?+
Which companies buy Lenalidomide from Indian manufacturers?+
Where does Lenalidomide exported from India go?+
What is the market share of the top Lenalidomide supplier from India?+
What is the average shipment value for Lenalidomide exports from India?+
Is Lenalidomide manufactured in India and exported globally?+
Which country imports the most Lenalidomide from India?+
Who are the buyers of Lenalidomide in Japan?+
How concentrated is the Lenalidomide supplier market in India?+
How do I find verified buyers for Lenalidomide in specific countries?+
Lenalidomide Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Lenalidomide exporter with a 53.8% market share and $475.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 237 suppliers collectively account for 98.1% of all tracked Lenalidomide exports, with a combined trade value of $883.1M.
- 3United States is the largest destination market, absorbing 96.7% of India's Lenalidomide exports ($853.7M). Japan (0.6%) and Netherlands (0.4%) follow.
- 4With 2.7K total shipments averaging $324.2K each, the Lenalidomide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include SUN PHARMACEUTICAL INDUSTRIES,INC.., SUN PHARMACEUTICAL INDUSTRIES,INC.., AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 122 countries
Network value: $883.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lenalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lenalidomide.
- 2.Flow Mapping: 237 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,724 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 122 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,724 Verified Shipments
237 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists